Omeros | OMER - Ebit





Ebit Cambiamento Data
Adma Biologics USD 59.23M 3.52M 2026-03
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Cytokinetics USD -181.23M 2.86M 2026-03
Gilead Sciences USD 2.68B 284M 2026-03
Heron Therapeutics USD 38K 3.83M 2025-12
Immunic USD -23.33M 2.67M 2025-12
Insmed USD -200.28M 49.43M 2026-03
Knight Therapeutics CAD 6.21M 3.27M 2025-12
MacroGenics USD -31.88M 19.79M 2026-03
Omeros USD -48.15M 7.25M 2023-09
Pacira USD 4.62M 1.43M 2026-03
Pfizer USD 4.99B 340M 2026-03
Sarepta Therapeutics USD 358.43M 768.52M 2026-03
United Therapeutics USD 325.8M 340.4M 2026-03
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03
Xoma USD -10.08M 4.4M 2024-06